Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients.

Moore CL, Besarab A, Ajluni M, Soi V, Peterson EL, Johnson LE, Zervos MJ, Adams E, Yee J.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1232-9. doi: 10.2215/CJN.11291113. Epub 2014 Jun 26.

2.

Tunneled catheters with taurolidine-citrate-heparin lock solution significantly improve the inflammatory profile of hemodialysis patients.

Fontseré N, Cardozo C, Donate J, Soriano A, Muros M, Pons M, Mensa J, Campistol JM, Navarro-González JF, Maduell F.

Antimicrob Agents Chemother. 2014 Jul;58(7):4180-4. doi: 10.1128/AAC.02421-14. Epub 2014 May 12.

3.

A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients--the HEALTHY-CATH trial.

Broom JK, Krishnasamy R, Hawley CM, Playford EG, Johnson DW.

BMC Nephrol. 2012 Nov 2;13:146. doi: 10.1186/1471-2369-13-146.

4.

Antifungal lock therapy.

Walraven CJ, Lee SA.

Antimicrob Agents Chemother. 2013 Jan;57(1):1-8. doi: 10.1128/AAC.01351-12. Epub 2012 Oct 15. Review.

5.

Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis.

Campos RP, do Nascimento MM, Chula DC, Riella MC.

J Am Soc Nephrol. 2011 Oct;22(10):1939-45. doi: 10.1681/ASN.2010121306. Epub 2011 Aug 18.

6.

Mechanical integrity of hemodialysis catheters after exposure to a novel catheter lock solution.

Aslam S, Darouiche RO.

Infect Control Hosp Epidemiol. 2010 Nov;31(11):1124-9. doi: 10.1086/656749.

7.

Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis.

Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya CK, Sweet SJ.

Clin J Am Soc Nephrol. 2010 Oct;5(10):1799-804. doi: 10.2215/CJN.01270210. Epub 2010 Jul 1.

8.

Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients.

Broom JK, O'Shea S, Govindarajulu S, Playford EG, Hawley CM, Isbel NM, Campbell SB, Mudge DW, Carpenter S, Johnson BC, Underwood NP, Johnson DW.

BMC Nephrol. 2009 Aug 20;10:23. doi: 10.1186/1471-2369-10-23.

9.

Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens).

Steczko J, Ash SR, Nivens DE, Brewer L, Winger RK.

Nephrol Dial Transplant. 2009 Jun;24(6):1937-45. doi: 10.1093/ndt/gfn776. Epub 2009 Jan 30.

10.

Use of Tenckhoff catheter for peritoneal dialysis in terminal renal failure.

Lankisch PG, Tönnis HJ, Fernandez-Redo E, Girndt J, Kramer P, Quellhorst E, Scheler F.

Br Med J. 1973 Dec 22;4(5894):712-3.

Supplemental Content

Loading ...
Support Center